InvestorsHub Logo
icon url

georgejjl

11/12/17 10:38 AM

#203459 RE: DaubersUP #203457

DaubersUP, I agree!!!

"Potentially Best In Class" - I have done the research on current OM drugs. I can confirm that even if we stick with interim data sets...and we have room to drop those numbers we will be BEST IN CLASS!

Some posters here feel that the 70% will only go higher though. If we see 80-90% prevention rates. I'd expect a deal to happen very quickly. Jimo

I'll be happy in the 65-75% prevention rate.



I believe that the Brilacidin OM trial results will be better than most expected at about 14% of the subjects using the Brilacidin swish and spit treatment developing a short term OM of grade 3 or higher.

Good luck and GOD bless,

George
icon url

runninggirl2016

11/12/17 11:27 AM

#203466 RE: DaubersUP #203457

Daubers the rate of no SOM was 78.8%(7 of 9). The 1 patient had SOM for only 3 days so we were 3 days away from 89%!!!!

Anybody wonder why we haven't heard anything on UP in like 5 months?:):)

Also anyone ever wonder why we have Biofilms listed in the Brilacdin Therapeutic Circle on the NEW Innovation website? We know IPX isn't testing it. So who could it be and why is it STILL there:):):):):):):):)


The FUDS can't beat up UP/OM/Absssi data so they try to destroy P and K. That's their game. A game they will lose...BADLY and SOON!!!


tic toc kaBoooooooooOM